Skip to main content

Breztri Aerosphere News

Study Compares Single-Inhaler Triple Therapies for Treatment of COPD

FRIDAY, Jan. 3, 2025 – For patients with chronic obstructive pulmonary disease (COPD), budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with...

FDA Approves Breztri Aerosphere (budesonide/glycopyrrolate/formoterol fumarate) for the Maintenance Treatment of COPD

24 July 2020 – AstraZeneca’s Breztri Aerosphere (budesonide/glycopyrrolate/formoterol fumarate) has been approved in the US for the maintenance treatment of patients with chronic obstructive p...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Chronic Obstructive Pulmonary Disease

Breztri Aerosphere patient information at Drugs.com